Literature DB >> 13475492

The potentiation of exogenous insulin by tolbutamide in depancreatized dogs.

R CAREN, L CORBO.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/effects; INSULIN/effects

Mesh：

Substances：

Year:  1957        PMID： 13475492      PMCID： PMC1072758          DOI： 10.1172/JCI103551

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  Studies on the mechanism of action of the sulfonylureas.

Authors:  I B FRITZ; R LEVINE; J V MORTON; M WEINSTEIN
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

2.  Acute effects of orinase on peripheral glucose utilization.

Authors:  A S GILBERTSEN; F C GOETZ; V JOSEPHSON
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

3.  Clinical experience with orinase.

Authors:  H DOLGER
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

4.  Action of butyltolylsulfonylurea on liver glycogenolysis.

Authors:  J M TYBERGHEIN; Y D HALSEY; R H WILLIAMS
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

5.  The action of BZ-55 in dogs. I. Observations on depancreatized and Houssay dogs.

Authors:  A SIREK; O V SIREK
Journal:  Can Med Assoc J       Date:  1956-06-15       Impact factor: 8.262

6.  The action of BZ-55 in dogs. II. Observations on depancreatized and metahypophyseal diabetic dogs.

Authors:  J CAMPBELL
Journal:  Can Med Assoc J       Date:  1956-06-15       Impact factor: 8.262

7.  In vitro studies on the action of sulfonamide hypoglycemic agents.

Authors:  M VAUGHAN
Journal:  Science       Date:  1956-05-18       Impact factor: 47.728

8.  The inhibition of insulinase by hypoglycemic sulfonamides.

Authors:  I A MIRSKY; G PERISUTTI; D DIENGOTT
Journal:  Metabolism       Date:  1956-03       Impact factor: 8.694

9.  [The use of some sulfamide drugs in the treatment of experimental diabetes mellitus; personal reseasrch (1942-1946)].

Authors:  A LOUBATIERES
Journal:  Presse Med       Date:  1955-12-10       Impact factor: 1.228

10.  Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).

Authors:  R C ANDERSON; W R KIRTLEY; A S RIDOLFO; M A ROOT
Journal:  Diabetes       Date:  1956 Sep-Oct       Impact factor: 9.461
View more
  5 in total

1.  Tolbutamide hypoglycemia in acutely depancreatized dogs.

Authors:  M KURTZ; C M HOLTZMAN; E MEILMAN
Journal:  J Clin Invest       Date:  1959-06       Impact factor: 14.808

Review 2.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 3.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Comparison of response to intravenously administered sodium tolbutamide in milk diabetic and non-diabetic subjects.

Authors:  R H UNGER; L L MADISON
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

5.  The sulphonylurea drug, glimepiride, stimulates release of glycosylphosphatidylinositol-anchored plasma-membrane proteins from 3T3 adipocytes.

Authors:  G Müller; E A Dearey; J Pünter
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.